IP Verse

Method For Prediction Of An Immune Response Against Mismatched Human Leukocyte Antigens - EP2917735

The patent EP2917735 was granted to UMC Utrecht Holding on Sep 22, 2021. The application was originally filed on Nov 8, 2013 under application number EP13788993A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2917735

UMC UTRECHT HOLDING
Application Number
EP13788993A
Filing Date
Nov 8, 2013
Status
Patent Maintained As Amended
Aug 20, 2021
Grant Date
Sep 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DRK BLUTSPENDEDIENST BADEN WURTTEMBERG HESSEN GEMEINNUTZIGEApr 12, 2019WITTEADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2011135617
OPPOSITIONEP2917735

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- A C Papassavas ET AL, "RECIPIENT SELECTION Definition of the Immunogenic HLA Epitopes Based on an Epitope Prediction Algorithm", Transplantation Proceedings, (20020901), vol. 34, pages 2049 - 2052, XP055274558-
EXAMINATION- Henny G. Otten ET AL, "Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation", Human Immunology, (20130301), vol. 74, no. 3, doi:10.1016/j.humimm.2012.12.004, ISSN 0198-8859, pages 290 - 296, XP055097518
EXAMINATION- D. S. Deluca ET AL, "High-throughput minor histocompatibility antigen prediction", BIOINFORMATICS., GB, (20090701), vol. 25, no. 18, doi:10.1093/bioinformatics/btp404, ISSN 1367-4803, pages 2411 - 2417, XP055274554
EXAMINATION- T. ANDREW BINKOWSKI ET AL, "Predicting HLA Class I Non-Permissive Amino Acid Residues Substitutions", PLOS ONE, (20120808), vol. 7, no. 8, doi:10.1371/journal.pone.0041710, pages 1 - 12, XP055274538
EXAMINATION- Chen Yanover ET AL, "HLA mismatches and hematopoietic cell transplantation: Structural simulations assess the impact of changes in peptide binding specificity on transplant outcome", Immunome research, England, (20110501), vol. 7, no. 2, pages 1 - 22, XP055274548
INTERNATIONAL-SEARCH-REPORT- MARLIES K.A DANKERS ET AL, "The HLA-DR phenotype of the responder is predictive of humoral response against HLA class i antigens", HUMAN IMMUNOLOGY, (20040101), vol. 65, no. 1, doi:10.1016/j.humimm.2003.09.017, ISSN 0198-8859, pages 13 - 19, XP055097516 [Y] 1-39 * whole document, especially p. 14, col. 1, par. 3 - col. 2, par. 5; p. 15, col. 1, par. 1 - p. 17, col. 1, bridging par.; p. 18, col. 1, par. 1 - col. 2, par. 1; table 2 *
INTERNATIONAL-SEARCH-REPORT- RENÉ J DUQUESNOY, "HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm", HUMAN IMMUNOLOGY, (20020501), vol. 63, no. 5, doi:10.1016/S0198-8859(02)00382-8, ISSN 0198-8859, pages 339 - 352, XP055097515 [X] 1,4-12,14,15,17,18,21,24-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- CLAAS F H J, "Predictive parameters for in vivo alloreactivity", TRANSPLANT IMMUNOLOGY, XX, XX, (20020801), vol. 10, no. 2-3, doi:10.1016/S0966-3274(02)00060-6, pages 137 - 142, XP002249197 [X] 1,4-12,14,15,17,18,21,24-39 * whole document, especially abstract, p. 140, col. 1, par. 2- col. 2, par. 1 *
INTERNATIONAL-SEARCH-REPORT- REINSMOEN N L, "Cellular methods used to evaluate the immune response in transplantation", TISSUE ANTIGENS, MUNKSGAARD, COPENHAGEN, DK, (20020801), vol. 59, no. 4, doi:10.1034/J.1399-0039.2002.590401.X, ISSN 0001-2815, pages 241 - 250, XP002249198 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- URBAN SESTER ET AL, "Rapid Identification of Preformed Alloreactive T Cells for Use in a Clinical Setting", TRANSPLANTATION, (20040801), vol. 78, no. 4, doi:10.1097/01.TP.0000131949.59284.4D, ISSN 0041-1337, pages 607 - 614, XP055058763 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- LIN HONG HUANG ET AL, "Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research", BMC BIOINFORMATICS, BIOMED CENTRAL, LONDON, GB, (20081212), vol. 9, no. Suppl 12, doi:10.1186/1471-2105-9-S12-S22, ISSN 1471-2105, page S22, XP021041907 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- WANG PENG ET AL, "A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach", PLOS COMPUTATIONAL BIOLOGY, PUBLIC LIBRARY OF SCIENCE, US, (20080401), vol. 4, no. 4, doi:10.1371/JOURNAL.PCBI.1000048, ISSN 1553-734X, pages E1000048 - 1, XP002598739 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- PAPASSAVAS A C, "HLA peptide-mediated strategies for modulation of cellular and humoral immune response in transplantation", CURRENT PHARMACOGENOMICS, BENTHAM SCIENCE PUBLISHERS, US, (20030301), vol. 1, no. 1, doi:10.2174/1570160033378330, ISSN 1570-1603, pages 17 - 36, XP009088516 [A] 1-39 * the whole document *
OPPOSITION- PAPASSAVAS A.C. et al., "Recipient selection: Definition of the immuno- genic HLA epitopes based on an epitope prediction algorithm", Trans- plantation Proceedings, (20020000), vol. 34, pages 2049 - 2052, XP055274558-
OPPOSITION- THUS KIRSTEN A. et al., "50-OR: Predicted indirectly recognizable HLA epitopes correlate with chronic graft-versus-host disease am relapse- related mortality in pediatric patients after cord blood transplantation", Human Immunology, (20130000), vol. 74, page 39, XP055584894-
OPPOSITION- OTTEN H.G. et al., "Predicted indirectly recognizable HLA epitopes pre- sented by HLA-DR correlate with the de novo development of donor- specific HLA IgG antibodies after kidney transplantation", Human Im- munology, (20130000), vol. 74, pages 290 - 296, XP055097518
OPPOSITION- DELUCA D.S., "Databases and onthologies: High throughput minor histocompatibility antigen prediction", Bioinformatics Advance Access, (20090701), pages 1 - 7, XP055274554
OPPOSITION- BINKOWSKI T.A. et al., "Predicting HLA Class I non-permissive amino-acid residues substitutions", PLoS ONE, (20120000), vol. 7, no. 8, pages 1 - 12, XP055274538
OPPOSITION- YANOVER C. et al., "HLA mismatches and hematopoietic cell transplanta- tion: Structural simulations assess the impact of changes in peptide binding specificity on transplant outcome", NIH Public Access, (20110000), vol. 7, no. 2, pages 1 - 22, XP055274548
OTHER- PAPASSAVAS A.C. et al., "Recipient selection: Definition of the immunogenic HLA epitopes based on an epitope prediction algorithm", Transplantation Proceedings, (20020000), vol. 34, pages 2049 - 2052, XP055274558-
OTHER- OTTEN H.G. et al., "Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation", Human Immunology, (20130000), vol. 74, pages 290 - 296, XP055097518
OTHER- DELUCA D.S., "High throughput minor histocompatibility antigen prediction", Databases and onthologies, (20090701), pages 1 - 7, XP055274554
OTHER- BINKOWSKI T.A. et al., "Predicting HLA Class I non permissive amino-acid residues substitutions", PLoS ONE, (20120000), vol. 7, no. 8, pages 1 - 12, XP055274538
OTHER- YANOVER C et al., "HLA mismatches and hematopoietic cell transplantation: Structural simulations assess the impact of changes in peptide binding specificity on transplant outcome", Immunome research, (20110000), vol. 7, no. 2, pages 1 - 22, XP055274548

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents